The α2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells
- 29 October 1991
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 204 (1) , 41-48
- https://doi.org/10.1016/0014-2999(91)90833-c
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Potassium selective ion channels in insulin-secreting cells: physiology, pharmacology and their role in stimulus-secretion couplingBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1991
- Tolbutamide excites rat glucoreceptive ventromedial hypothallamic neurones by indirect inhibition of ATP‐K+ channelsBritish Journal of Pharmacology, 1990
- Properties and functions of ATP-sensitive K-channelsCellular Signalling, 1990
- The effects of cromakalim on ATP‐sensitive potassium channels in insulin‐secreting cellsBritish Journal of Pharmacology, 1990
- Stimulation of insulin secretion by efaroxan may involve interaction with potassium channelsEuropean Journal of Pharmacology, 1990
- Protein phosphorylation is required for diazoxide to open ATP‐sensitive potassium channels in insulin (RINm5F) secreting cellsFEBS Letters, 1989
- Effects of α-adrenergic antagonists on insulin secretion from rat pancreatic isletsBiochemical Society Transactions, 1988
- Intracellular ATP directly blocks K+ channels in pancreatic B-cellsNature, 1984
- .alpha.-Adrenoceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on .alpha.-adrenoreceptor activityJournal of Medicinal Chemistry, 1984
- Diazoxide effects on biphasic insulin release: “adrenergic” suppression and enhancement in the perifused rat pancreasJournal of Clinical Investigation, 1971